CATALOGO DEI PRODOTTI DELLA RICERCA

ROSSINI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.859
EU - Europa 12.390
AS - Asia 3.506
SA - Sud America 54
OC - Oceania 20
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 15
Totale 28.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.817
GB - Regno Unito 5.124
CN - Cina 3.123
IT - Italia 1.544
FR - Francia 1.150
SE - Svezia 1.071
DE - Germania 1.043
IE - Irlanda 1.037
FI - Finlandia 752
UA - Ucraina 266
TR - Turchia 138
RU - Federazione Russa 113
BE - Belgio 68
VN - Vietnam 66
NL - Olanda 49
CA - Canada 37
KR - Corea 37
RO - Romania 37
IN - India 34
ES - Italia 32
IR - Iran 28
AT - Austria 26
BR - Brasile 24
JP - Giappone 20
AU - Australia 16
HK - Hong Kong 16
CL - Cile 14
CH - Svizzera 11
SG - Singapore 11
PL - Polonia 10
EU - Europa 8
PT - Portogallo 8
SK - Slovacchia (Repubblica Slovacca) 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BG - Bulgaria 6
IL - Israele 6
ZA - Sudafrica 6
GR - Grecia 5
QA - Qatar 5
AR - Argentina 4
EG - Egitto 4
HR - Croazia 4
LV - Lettonia 4
MX - Messico 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
EC - Ecuador 3
MA - Marocco 3
PE - Perù 3
PH - Filippine 3
SI - Slovenia 3
BD - Bangladesh 2
ID - Indonesia 2
IQ - Iraq 2
LK - Sri Lanka 2
MK - Macedonia 2
MN - Mongolia 2
RS - Serbia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
VE - Venezuela 2
A1 - Anonimo 1
AL - Albania 1
BO - Bolivia 1
CO - Colombia 1
CU - Cuba 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
NG - Nigeria 1
PY - Paraguay 1
SC - Seychelles 1
SM - San Marino 1
TH - Thailandia 1
TW - Taiwan 1
Totale 28.859
Salva come PNG Salva come JPEG
Città #
Southend 4.797
Jacksonville 2.246
Chandler 2.205
Woodbridge 1.244
Dublin 1.021
Ann Arbor 959
Houston 671
Ashburn 643
Beijing 489
Lawrence 448
Princeton 448
Wilmington 424
Jinan 325
Nanjing 293
Shenyang 277
New York 246
Redmond 238
Verona 204
Bologna 200
Sindelfingen 179
Hebei 175
Helsinki 166
Tianjin 146
Changsha 132
Milan 123
Ningbo 112
Haikou 110
Nanchang 105
Zhengzhou 102
Boardman 95
Jiaxing 87
Hangzhou 83
Taizhou 83
Redwood City 72
Seattle 68
Taiyuan 67
Norwalk 65
Brussels 61
Guangzhou 59
Washington 55
Falls Church 51
Fairfield 48
Rome 44
Lanzhou 43
Dearborn 42
Fuzhou 42
Los Angeles 42
Dong Ket 41
Orani 40
San Francisco 38
Chicago 31
Düsseldorf 31
Seoul 27
Detroit 24
Vienna 24
Dongguan 23
Cagliari 22
Lancaster 22
Sanayi 20
Nürnberg 18
Toronto 18
Venice 18
Esslingen am Neckar 16
Groningen 16
Menlo Park 16
Torino 16
Paris 14
Lappeenranta 13
Leawood 13
Frankfurt am Main 12
London 12
Auburn Hills 11
Cambridge 11
Bolzano 10
Kemerovo 10
San Diego 10
Tappahannock 10
Turin 10
Amsterdam 9
Brescia 9
Clearwater 9
Hong Kong 9
Miami 9
Philadelphia 9
Timisoara 9
Ardabil 8
Boydton 8
Florianópolis 8
Greifswald 8
Montréal 8
Novokuznetsk 8
Phoenix 8
Saint Louis 8
San Mateo 8
Berlin 7
Bârlad 7
Catania 7
Mehlingen 7
Naples 7
Shanghai 7
Totale 20.609
Salva come PNG Salva come JPEG
Nome #
Fibromialgia. Razionale e risultati del trattamento con L-Acetilcarnitina. 368
Epidemiology and Economic Burden of Osteoporosis in Italy 289
Teriparatide and denosumab combination therapy and skeletal metabolism 240
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 211
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 167
Artrite Reumatoide e Metabolismo Minerale 155
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 143
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 133
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 128
Incidenza di ipovitaminosi D nel Nord Italia 125
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 125
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 123
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 123
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 115
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 112
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 112
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 111
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 110
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 110
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 109
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 108
Rapporti tra sistema immune e metabolismo osseo 107
Prevalence and incidence of rheumatoid arthritis in Italy. 106
Bone metabolism in patients with anorexia nervosa and amenorrhoea 106
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 105
DXA bone mineral density in males: retrospective study in real life. 104
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 104
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 104
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 103
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 103
[Therapeutic strategies in osteoporosis: whom and when to treat] 102
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 101
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 98
Osteopetrosi 98
Age-related bone loss in postmenopausal women 98
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 98
Guidelines for the diagnosis, prevention and management of osteoporosis 98
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 98
The renal handling of calcium: influence of parathyroid hormone secretion 97
Osteoporosis treatment: why ibandronic acid? 97
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 97
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 96
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 96
Vitamin D levels in patients with psoriasis with or without arthritis 96
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 95
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 95
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 95
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH Agonist. 94
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 94
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 94
Anti-CCP antibodies and bone 94
Prevalence of osteoporosis in patients affected by mastocytosis 93
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 93
Anabolic steroids in corticosteroid-induced osteoporosis 92
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 92
Incidenza di ipovitaminosi D nel Nord Italia 91
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 91
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 91
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 90
Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis. 90
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 89
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 89
Safety issues and adverse reactions with osteoporosis management 89
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 89
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 89
Could γ\δ T-cells explain zoledronic acid adverse events? 89
Bone turnover markers in patients with osteogenesis imperfecta 88
Osteoporosi: progressi nella diagnosi e nel trattamento 88
Bone turnover markers in patients with osteogenesis imperfecta. 87
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 87
The initiative on hip fractures of the Veneto Region 86
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 86
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 86
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 85
Drug-induced osteonecrosis of the jaw: the state of the art 85
The radiological assessment of vertebral osteoporosis 84
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 84
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 84
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 84
The radiological assessment of vertebral osteoporosis 83
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. 83
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 83
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 83
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 83
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 83
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 82
Peak bone mass and peak bone density. 82
Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study. 81
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 81
Osteoporisis costs in Italy: interim results of the block study 81
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 81
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 81
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 81
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 80
Transdermal Estradiol in the treatment of postmenopausale bone loss. 80
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 80
Effects of two oral doses of alendronate in the treatment of Paget’s disease of bone. 80
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 80
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 80
Bone involvement in patient with clonal mast cell disorders 80
Totale 10.369
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.483
article - articoli 89.259
book - libri 0
conference - conferenze 1.408
curatela - curatele 0
other - altro 211
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.605
Totale 186.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019159 0 0 0 0 0 0 0 0 0 40 29 90
2019/20203.692 570 44 32 364 427 395 359 369 198 321 139 474
2020/20213.886 427 729 113 436 497 426 82 243 307 27 441 158
2021/20223.278 240 811 49 158 156 128 61 185 279 97 305 809
2022/20236.844 562 555 704 1.182 607 1.654 87 384 733 75 226 75
2023/20242.775 179 270 330 419 404 534 181 274 58 126 0 0
Totale 29.558